Nutraceuticals:

N-acetylcysteine (NAC)

N-acetylcysteine (NAC) is a supplement and prescription drug with promising analgesic, anti-inflammatory, and antioxidant benefits which help maintain cellular oxidation-reduction balance. For this reason, its therapeutic benefits  conditions associated with oxidative stress including chronic pain.

 

“Our greatest weakness lies in giving up. The most certain way to succeed is always to try just one more time.” – Thomas A. Edison

See:

N-acetylcysteine (NAC)

N-acetylcysteine (NAC) is primarily valued for its role as a precursor to glutathione, a powerful antioxidant, and for its ability to break up mucus. Its benefits are mostly tied to its antioxidant and anti-inflammatory properties.

Key Benefits and Potential Uses of NAC

NAC has various proposed uses supported by varying levels of evidence (1): 
  1. Acetaminophen Overdose Treatment: NAC is an FDA-approved antidote administered intravenously or orally to prevent liver and kidney damage from acetaminophen (Tylenol) poisoning. It has been used for many years with this application and it is considered safe.
  2. Respiratory Condition Relief: As a mucolytic agent, NAC helps thin and loosen mucus in the airways, making it useful for conditions like chronic obstructive pulmonary disease (COPD), chronic bronchitis, and cystic fibrosis.
  3. Detoxification Support: By boosting glutathione levels, NAC helps the body detoxify various drugs and environmental toxins, supporting liver and kidney function.
  4. Mental Health Support: Research suggests NAC may help regulate glutamate, a key neurotransmitter, and could serve as an adjunctive treatment for conditions like schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), and substance use disorders, though results are mixed and more research is needed.
  5. Brain Health: NAC’s neuroprotective effects, by fighting oxidative stress and inflammation, show promise in animal models for neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.
  6. Fertility Improvement: In some cases, NAC may improve fertility in both men and women by reducing oxidative stress and, in women with polycystic ovary syndrome (PCOS), by improving ovulation and insulin resistance when used with other treatments.
  7. Immune System Support: NAC’s ability to enhance glutathione levels may help improve immune function and has been studied for its potential to reduce the severity and frequency of influenza symptoms.
  8. Heart Health: NAC may help reduce the risk of heart disease by lessening oxidative damage to heart tissue and improving blood flow by increasing nitric oxide production.

Mechanisms of Action:

NAC exerts analgesic effects through multiple complementary mechanisms relevant to chronic pain pathophysiology:

  • Antioxidant activity: NAC replenishes glutathione (GSH) stores and reduces oxidative stress markers (lipid hydroperoxides, malondialdehyde) in the spinal cord of animals with neuropathic pain.[1][2]
  • Anti-inflammatory effects: NAC reduces pro-inflammatory cytokines (TNF-α, IL-6, IL-8) and inhibits NF-κB signaling, with meta-analyses of clinical trials showing significant reductions in IL-8, homocysteine, and MDA levels.[3]
  • Inhibition of matrix metalloproteinases (MMPs): NAC suppresses MMP-9 and MMP-2 activity, blocking the maturation of IL-1β and reducing neuronal activation and microglial activation in neuropathic pain models.[4]
  • Enhancement of mGlu2/3 receptor activation: NAC activates the cystine/glutamate antiporter (System xc-), increasing extracellular glutamate and reinforcing endogenous activation of mGlu2 receptors, which inhibits nociceptive transmission in both animals and humans.[5][6]
  • Antagonism of NGF-TrkA signaling: NAC interferes with nerve growth factor (NGF)-induced activation of TrkA receptors by disrupting disulfide bonds, potentially contributing to its analgesic activity in pain states sustained by NGF hyperactivity.[7]
  • Reduction of nitric oxide metabolites: NAC decreases NO levels in the spinal cord of rats with neuropathic pain, independent of its role as a GSH precursor.[1]

Preclinical Evidence:

Animal studies consistently demonstrate that NAC (50-200 mg/kg orally or 100 mg/kg intraperitoneally) attenuates mechanical and thermal hyperalgesia in models of neuropathic pain (chronic constriction injury), inflammatory pain (formalin test, complete Freund’s adjuvant), and cancer-induced bone pain.[4][5][1][2] NAC inhibits central sensitization by suppressing spinal glial activation, reducing phosphorylation of pain-related kinases (PKCγ, NMDAR1, MAPKs), and normalizing oxidative stress biomarkers.[4][1][2]

Clinical Evidence:

A systematic review and meta-analysis of nine clinical studies (n=863) evaluated NAC for chronic pain conditions including sickle cell disease, complex regional pain syndrome, pelvic pain/endometriosis, rheumatoid arthritis, diabetic neuropathy, and chronic neuropathic pain.[8] The pooled analysis of three RCTs showed that NAC did not significantly reduce pain intensity, improve functional outcomes, or enhance quality of life in the random-effects model; however, sensitivity analysis using a fixed-effect model demonstrated a significant effect for pain and function.[8] The authors concluded that while there is some evidence for analgesic efficacy in certain conditions, the data are insufficient to provide definitive recommendations.

In healthy human volunteers, a single oral dose of NAC (1.2 g) significantly reduced pain ratings to laser stimuli and amplitudes of laser-evoked potentials without changing thermal pain thresholds, demonstrating inhibition of nociceptive transmission.[6] This effect was mediated by mGlu2/3 receptor activation, as confirmed in animal studies.[6]

A systematic review of dietary interventions for neuropathic pain found conflicting or insufficient evidence for NAC in chemotherapy-induced peripheral neuropathy (CIPN), though further research into NAC was deemed warranted.[9]

Safety and Tolerability:

NAC has a well-established safety profile from decades of clinical use as a mucolytic and antidote to acetaminophen overdose.[10][11][12] Adverse events in chronic pain trials were inconsistently reported, but NAC is generally well tolerated with mild gastrointestinal side effects being the most common.[8][10]

In summary, NAC shows mechanistic promise for managing chronic pain through antioxidant, anti-inflammatory, and neuromodulatory effects that target systemic inflammation, oxidative stress, and central sensitization. Preclinical evidence is robust, but clinical trial data remain limited and inconclusive, with some evidence supporting benefit in specific neuropathic and inflammatory pain conditions. Larger, high-quality RCTs are needed to establish NAC’s role in pain management.

References:

  • Govoni S, et al.[7] Int J Mol Sci. 2023;25(1):206. PMID: 38203377
  • Mohiuddin M, et al.[8] Pain Med. 2021;22(12):2896-2907. PMID: 33560443
  • Li J, et al.[4] Pain. 2016;157(8):1711-1723. PMID: 27075430
  • Bernabucci M, et al.[5] Mol Pain. 2012;8:77. PMID: 23088864
  • Horst A, et al.[1] Neurosci Lett. 2014;569:163-8. PMID: 24704379
  • Truini A, et al.[6] Mol Pain. 2015;11:14. PMID: 25889381
  • Tenório MCDS, et al.[10] Antioxidants. 2021;10(6):967. PMID: 34208683
  • Horst A, et al.[2] Braz J Med Biol Res. 2017;50(12):e6533. PMID: 29069230
  • Raghu G, et al.[11] Curr Neuropharmacol. 2021;19(8):1202-1224. PMID: 33380301
  • Tieu S, et al.[12] Antioxidants. 2023;12(10):1867. PMID: 37891946
  • Faghfouri AH, et al.[3] Eur J Pharmacol. 2020;884:173368. PMID: 32726657
  • Frediani JK, et al.[9] Pain Pract. 2024;24(1):186-210. PMID: 37654090

References

  1. Effect of N-Acetylcysteine on the Spinal-Cord Glutathione System and Nitric-Oxide Metabolites in Rats With Neuropathic Pain. Horst A, Kolberg C, Moraes MS, et al. Neuroscience Letters. 2014;569:163-8. doi:10.1016/j.neulet.2014.03.063.
  2. Effects of N-Acetylcysteine on Spinal Cord Oxidative Stress Biomarkers in Rats With Neuropathic Pain. Horst A, de Souza JA, Santos MCQ, et al. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 2017;50(12):e6533. doi:10.1590/1414-431X20176533.
  3. The Effects of N-Acetylcysteine on Inflammatory and Oxidative Stress Biomarkers: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. Faghfouri AH, Zarezadeh M, Tavakoli-Rouzbehani OM, et al. European Journal of Pharmacology. 2020;884:173368. doi:10.1016/j.ejphar.2020.173368.
  4. N-Acetyl-Cysteine Attenuates Neuropathic Pain by Suppressing Matrix Metalloproteinases. Li J, Xu L, Deng X, et al. Pain. 2016;157(8):1711-1723. doi:10.1097/j.pain.0000000000000575.
  5. N-Acetyl-Cysteine Causes Analgesia by Reinforcing the Endogenous Activation of Type-2 Metabotropic Glutamate Receptors. Bernabucci M, Notartomaso S, Zappulla C, et al. Molecular Pain. 2012;8:77. doi:10.1186/1744-8069-8-77.
  6. N-Acetyl-Cysteine, a Drug That Enhances the Endogenous Activation of Group-Ii Metabotropic Glutamate Receptors, Inhibits Nociceptive Transmission in Humans. Truini A, Piroso S, Pasquale E, et al. Molecular Pain. 2015;11:14. doi:10.1186/s12990-015-0009-2.
  7. N-Acetylcysteine Antagonizes NGF Activation of TrkA Through Disulfide Bridge Interaction, an Effect Which May Contribute to Its Analgesic Activity. Govoni S, Fantucci P, Marchesi N, et al. International Journal of Molecular Sciences. 2023;25(1):206. doi:10.3390/ijms25010206.
  8. Efficacy and Safety of N-Acetylcysteine for the Management of Chronic Pain in Adults: A Systematic Review and Meta-Analysis. Mohiuddin M, Pivetta B, Gilron I, Khan JS. Pain Medicine (Malden, Mass.). 2021;22(12):2896-2907. doi:10.1093/pm/pnab042.
  9. The Role of Diet and Non-Pharmacologic Supplements in the Treatment of Chronic Neuropathic Pain: A Systematic Review. Frediani JK, Lal AA, Kim E, et al. Pain Practice : The Official Journal of World Institute of Pain. 2024;24(1):186-210. doi:10.1111/papr.13291.
  10. -Acetylcysteine (NAC): Impacts on Human Health. Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. Antioxidants (Basel, Switzerland). 2021;10(6):967. doi:10.3390/antiox10060967.
  11. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Raghu G, Berk M, Campochiaro PA, et al. Current Neuropharmacology. 2021;19(8):1202-1224. doi:10.2174/1570159X19666201230144109.
  12. N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals. Tieu S, Charchoglyan A, Paulsen L, et al. Antioxidants (Basel, Switzerland). 2023;12(10):1867. doi:10.3390/antiox12101867.

 

Mechanisms of Action and Rationale for NAC in Chronic Pain Management

N-acetylcysteine (NAC) acts as a potent antioxidant by replenishing intracellular glutathione, suppressing oxidative stress, and inhibiting NF-κB signaling, which reduces pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β.[1][2][3] NAC also uniquely antagonizes NGF-TrkA signaling, a pathway implicated in nociception and central sensitization, and enhances mGlu2/3 receptor activation, which inhibits nociceptive transmission in both animal models and humans.[1][4][5]

Evidence-Based Dosing Regimen for NAC

Clinical and preclinical studies support oral NAC doses ranging from 600 mg to 2400 mg per day for chronic pain management. A single oral dose of 1.2 g has been shown to inhibit nociceptive transmission in healthy volunteers.[4] Animal studies typically use 50–200 mg/kg orally for neuropathic pain, but human studies most commonly use 600–1200 mg/day, divided into two or three doses.[2][5][6] For a multi-nutraceutical regimen, 600–1200 mg/day is a reasonable starting dose, titrated based on tolerability and clinical response.

Synergistic Benefits of Multi-Nutraceutical Approach

Combining NAC with omega-3 fatty acids, curcumin, resveratrol, quercetin, and vitamin C is mechanistically rational, as these agents target complementary pain pathways—antioxidant, anti-inflammatory, and neuromodulatory.[7][8][9][10] This multimodal approach may enhance efficacy by suppressing systemic inflammation, oxidative stress, and central sensitization, as supported by reviews advocating individualized, multi-compound regimens for chronic pain.[7][8][10]

Safety Considerations

NAC has a well-established safety profile, with rare toxicity and mild gastrointestinal side effects at recommended doses.[3][11] Adverse event reporting in pain trials is inconsistent, but NAC is generally well tolerated. The long-term safety of multi-nutraceutical regimens is not fully established, and monitoring for interactions and cumulative effects is advised.[11][6]

Limitations and Evidence Gaps

Current clinical evidence for NAC in chronic pain is limited and inconclusive, with meta-analyses showing mixed results and a need for larger, high-quality RCTs.[11][6][12] The optimal dosing and efficacy of multi-nutraceutical combinations remain to be determined, and further research is needed to clarify their role in pain management.

In summary, an evidence-based regimen for NAC in a multi-nutraceutical approach to chronic pain management is 600–1200 mg/day orally, combined with omega-3 fatty acids, curcumin, resveratrol, quercetin, and vitamin C. This combination is mechanistically sound and generally safe, but robust clinical evidence for efficacy and long-term safety is still emerging.

See: Micronutrient Synergies for Pain

 

References

  1. N-Acetylcysteine Antagonizes NGF Activation of TrkA Through Disulfide Bridge Interaction, an Effect Which May Contribute to Its Analgesic Activity. Govoni S, Fantucci P, Marchesi N, et al. International Journal of Molecular Sciences. 2023;25(1):206. doi:10.3390/ijms25010206.
  2. N-Acetyl-Cysteine Attenuates Neuropathic Pain by Suppressing Matrix Metalloproteinases. Li J, Xu L, Deng X, et al. Pain. 2016;157(8):1711-1723. doi:10.1097/j.pain.0000000000000575.
  3. -Acetylcysteine (NAC): Impacts on Human Health. Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. Antioxidants (Basel, Switzerland). 2021;10(6):967. doi:10.3390/antiox10060967.
  4. N-Acetyl-Cysteine, a Drug That Enhances the Endogenous Activation of Group-Ii Metabotropic Glutamate Receptors, Inhibits Nociceptive Transmission in Humans. Truini A, Piroso S, Pasquale E, et al. Molecular Pain. 2015;11:14. doi:10.1186/s12990-015-0009-2.
  5. N-Acetyl-Cysteine Causes Analgesia by Reinforcing the Endogenous Activation of Type-2 Metabotropic Glutamate Receptors. Bernabucci M, Notartomaso S, Zappulla C, et al. Molecular Pain. 2012;8:77. doi:10.1186/1744-8069-8-77.
  6. Efficacy and Safety of N-Acetylcysteine for the Management of Chronic Pain in Adults: A Systematic Review and Meta-Analysis. Mohiuddin M, Pivetta B, Gilron I, Khan JS. Pain Medicine (Malden, Mass.). 2021;22(12):2896-2907. doi:10.1093/pm/pnab042.
  7. New Concepts of Chronic Pain and the Potential Role of Complementary Therapies. Wojcikowski K, Vigar VJ, Oliver CJ. Alternative Therapies in Health and Medicine. 2020;26(S1):18-31.
  8. Does Diet Play a Role in Reducing Nociception Related to Inflammation and Chronic Pain?. Bjørklund G, Aaseth J, Doşa MD, et al. Nutrition (Burbank, Los Angeles County, Calif.). 2019;66:153-165. doi:10.1016/j.nut.2019.04.007.
  9. Non-Drug Pain Relievers Active on Non-Opioid Pain Mechanisms. Marchesi N, Govoni S, Allegri M. Pain Practice : The Official Journal of World Institute of Pain. 2022;22(2):255-275. doi:10.1111/papr.13073.
  10. Insights on Nutrients as Analgesics in Chronic Pain. Bjørklund G, Chirumbolo S, Dadar M, et al. Current Medicinal Chemistry. 2020;27(37):6407-6423. doi:10.2174/0929867326666190712172015.
  11. Potential of N-Acetylcysteine in the Management of Low Back Pain: A Scoping Review of Studies in Humans and Animal Models. Sinigaglia G, Fortunato LM, Grillo ML, Partata WA. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 2025;58:e14382. doi:10.1590/1414-431X2025e14382.
  12. The Role of Diet and Non-Pharmacologic Supplements in the Treatment of Chronic Neuropathic Pain: A Systematic Review. Frediani JK, Lal AA, Kim E, et al. Pain Practice : The Official Journal of World Institute of Pain. 2024;24(1):186-210. doi:10.1111/papr.13291.

Clinical efficacy and safety of this multi-nutraceutical combination for chronic pain,

  1. The most relevant RCT studied a polyphenol supplement containing curcumin, resveratrol, rosemary extract, and ascorbic acid (vitamin C) in knee osteoarthritis patients. This combination significantly reduced pain, improved function and quality of life, and lowered systemic inflammation compared to ascorbic acid alone, with a favorable safety profile. However, this regimen did not include NAC, omega-3s, or quercetin, and was not compared to standard pharmacologic therapies.[1]
  2. Systematic reviews and meta-analyses support the efficacy of individual nutraceuticals (curcumin, omega-3s, vitamin C, NAC) for pain reduction and anti-inflammatory effects in chronic pain conditions such as osteoarthritis, neuropathic pain, and fibromyalgia. These reviews highlight that combinations may offer broader mechanistic coverage and potentially greater benefit, but direct evidence for multi-compound regimens is lacking.[2][3][4][5][6]
  3. For NAC specifically, a meta-analysis found mixed results for pain reduction in chronic pain conditions, with some evidence for benefit but insufficient data for definitive recommendations. Safety was generally good, but adverse event reporting was inconsistent.[3]
  4. Reviews and expert consensus recommend multimodal, individualized regimens using complementary nutraceuticals for chronic pain, based on mechanistic rationale and preclinical synergy, but emphasize the need for high-quality clinical trials to confirm efficacy and safety.[7][8][9][10]

Safety:

Available studies report good tolerability for individual and dual-agent nutraceutical regimens, with adverse events similar to or lower than placebo. Long-term safety and potential interactions in multi-compound regimens remain to be established.

Summary:

  • The best evidence supports the use of polyphenol combinations (curcumin, resveratrol, vitamin C) for pain and inflammation in osteoarthritis, and individual agents for other pain conditions.
  • Mechanistic and preclinical data support synergy, but clinical confirmation is needed.

References

  1. A Standardized Nutraceutical Supplement Contributes to Pain Relief, Improves Quality of Life and Regulates Inflammation in Knee Osteoarthritis Patients; A Randomized Clinical Trial. Valsamidou E, Amerikanou C, Tzavara C, et al. Heliyon. 2023;9(9):e20143. doi:10.1016/j.heliyon.2023.e20143.
  2. The Role of Diet and Non-Pharmacologic Supplements in the Treatment of Chronic Neuropathic Pain: A Systematic Review. Frediani JK, Lal AA, Kim E, et al. Pain Practice : The Official Journal of World Institute of Pain. 2024;24(1):186-210. doi:10.1111/papr.13291.
  3. Efficacy and Safety of N-Acetylcysteine for the Management of Chronic Pain in Adults: A Systematic Review and Meta-Analysis. Mohiuddin M, Pivetta B, Gilron I, Khan JS. Pain Medicine (Malden, Mass.). 2021;22(12):2896-2907. doi:10.1093/pm/pnab042.
  4. Nutraceutical Supplements in Management of Pain and Disability in Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Aghamohammadi D, Dolatkhah N, Bakhtiari F, Eslamian F, Hashemian M. Scientific Reports. 2020;10(1):20892. doi:10.1038/s41598-020-78075-x.
  5. A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms. Mathieu S, Soubrier M, Peirs C, et al. Nutrients. 2022;14(8):1607. doi:10.3390/nu14081607.
  6. Effects of Omega-3 Fatty Acids on Chronic Pain: A Systematic Review and Meta-Analysis. Xie L, Wang X, Chu J, et al. Frontiers in Medicine. 2025;12:1654661. doi:10.3389/fmed.2025.1654661.
  7. New Concepts of Chronic Pain and the Potential Role of Complementary Therapies. Wojcikowski K, Vigar VJ, Oliver CJ. Alternative Therapies in Health and Medicine. 2020;26(S1):18-31.
  8. Non-Drug Pain Relievers Active on Non-Opioid Pain Mechanisms. Marchesi N, Govoni S, Allegri M. Pain Practice : The Official Journal of World Institute of Pain. 2022;22(2):255-275. doi:10.1111/papr.13073.
  9. The Role of Phytochemicals in Managing Neuropathic Pain: How Much Progress Have We Made?. Sic A, Manzar A, Knezevic NN. Nutrients. 2024;16(24):4342. doi:10.3390/nu16244342.
  10. A Systematic Review and Meta-Analysis on the Role of Nutraceuticals in the Management of Neuropathic Pain in in Vivo Studies. Ilari S, Proietti S, Russo P, et al. Antioxidants (Basel, Switzerland). 2022;11(12):2361. doi:10.3390/antiox11122361.

Purchasing Supplements

When purchasing supplements reviewed on this web site and discussed with Dr. Ehlenberger, a discount on usual commercial pricing can be obtained by purchasing from Accurate Clinic’s online Supplement Store after acquiring the discount code from Accurate Clinic:

Accurate Clinic’s Supplement Store

 or call Toll-Free: 877-846-7122 (Option 1)

 

References:

N-Acetylcysteine (NAC) –  Overviews

  1. N-Acetylcysteine (NAC)- Impacts on Human Health – 2021

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

Accurate Supplement Prices

 

 

.